MPA | Pharmacy News

Hundreds of thousands of newly designed COVID boosters bound for Michigan could significantly tamp down a fall infection surge, according to data modeling. But even with new booster shots revamped to stop the latest variants, there is still plenty of uncertainty: Will people take the boosters? And even if lots of Michiganders roll up their sleeves, could the coronavirus evolve enough to du...

Read More

The Food and Drug Administration on Wednesday authorized updated versions of Pfizer-BioNTech’s and Moderna’s Covid booster shots that target the highly contagious BA.5 omicron subvariant. The FDA authorized Pfizer’s modified booster for people ages 12 and older; Moderna's shot was authorized for those 18 and up. People who’ve received the two-dose primar...

Read More

Moderna has requested regulatory clearance of its reformulated COVID-19 vaccine, which the company is prepared to start delivering next month with FDA's authorization. The updated product is configured to fight the strain of coronavirus that emerged in 2019 as well as the Omicron BA.4 and BA.5 subvariants now in heavy circulation. Based on favorable results from previous evaluation of a versio...

Read More

Pfizer and BioNTech have applied for FDA authorization of their reformulated COVID-19 booster dose, which targets Omicron subtypes BA.4 and BA.5 as well as the original strain of SARS-CoV-2. Omicron cases are now dominant in the United States, but research has suggested that currently approved vaccines are less effective against the mutation and its subtypes. Human trials of the modified vaccine a...

Read More

Time Magazine - Aug 23, 2022 The Federal Trade Commission recently launched an inquiry into the practices of pharmacy benefit managers, known in the industry as PBMs. PBMs are the hidden middlemen who were supposed to make drug distribution more efficient. Yet over time, they have grown in size and power, and research suggests they have contributed to the rapidly rising costs of presc...

Read More